96 related articles for article (PubMed ID: 21547739)
1. Introduction to section III: resources for CFTR research.
Amaral MD
Methods Mol Biol; 2011; 742():281-3. PubMed ID: 21547739
[TBL] [Abstract][Full Text] [Related]
2. Introduction to section III: biochemical methods to study CFTR protein.
Amaral MD; Lukacs GL
Methods Mol Biol; 2011; 741():213-8. PubMed ID: 21594787
[TBL] [Abstract][Full Text] [Related]
3. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
Clunes MT; Boucher RC
Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the disease liability of CFTR variants.
Sosnay PR; Castellani C; Corey M; Dorfman R; Zielenski J; Karchin R; Penland CM; Cutting GR
Methods Mol Biol; 2011; 742():355-72. PubMed ID: 21547743
[TBL] [Abstract][Full Text] [Related]
5. Developmental paradigm for early features of cystic fibrosis.
Larson JE; Cohen JC
Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
Jouret F; Bernard A; Hermans C; Dom G; Terryn S; Leal T; Lebecque P; Cassiman JJ; Scholte BJ; de Jonge HR; Courtoy PJ; Devuyst O
J Am Soc Nephrol; 2007 Mar; 18(3):707-18. PubMed ID: 17287432
[TBL] [Abstract][Full Text] [Related]
7. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
Soferman R
Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
[TBL] [Abstract][Full Text] [Related]
8. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
9. Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models.
Weiner SA; Caputo C; Bruscia E; Ferreira EC; Price JE; Krause DS; Egan ME
Pediatr Res; 2008 Jan; 63(1):73-8. PubMed ID: 18043508
[TBL] [Abstract][Full Text] [Related]
10. Genetics of cystic fibrosis.
Lommatzsch ST; Aris R
Semin Respir Crit Care Med; 2009 Oct; 30(5):531-8. PubMed ID: 19760540
[TBL] [Abstract][Full Text] [Related]
11. [Modifier genes and cystic fibrosis].
Corvol H; Flamant C; Vallet C; Clement A; Brouard J
Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
[TBL] [Abstract][Full Text] [Related]
12. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
13. Altered terminal glycosylation and the pathophysiology of CF lung disease.
Rhim AD; Stoykova LI; Trindade AJ; Glick MC; Scanlin TF
J Cyst Fibros; 2004 Aug; 3 Suppl 2():95-6. PubMed ID: 15463936
[TBL] [Abstract][Full Text] [Related]
14. Microarray mRNA expression profiling to study cystic fibrosis.
Ramachandran S; Clarke LA; Scheetz TE; Amaral MD; McCray PB
Methods Mol Biol; 2011; 742():193-212. PubMed ID: 21547734
[TBL] [Abstract][Full Text] [Related]
15. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.
Hardcastle J; Harwood MD; Taylor CJ
J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of cystic fibrosis: phenotypic analysis and research applications.
Wilke M; Buijs-Offerman RM; Aarbiou J; Colledge WH; Sheppard DN; Touqui L; Bot A; Jorna H; de Jonge HR; Scholte BJ
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S152-71. PubMed ID: 21658634
[TBL] [Abstract][Full Text] [Related]
17. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
18. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
[TBL] [Abstract][Full Text] [Related]
19. What is the role of the non-coding regions of the CFTR gene in cystic fibrosis?
Castaldo G; Tomaiuolo R
Expert Rev Respir Med; 2013 Aug; 7(4):327-9. PubMed ID: 23964622
[No Abstract] [Full Text] [Related]
20. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
